Ben Yonginsider trades

In SEC Form 4 filings, Ben Yong is listed as Chief Med & Dev Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT) and Director of Corbus Pharmaceuticals Holdings, Inc. (CRBP). In the last 90 days, Ben Yong sold $15.7K of Corbus Pharmaceuticals Holdings, Inc. (CRBP) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
BBOTBridgeBio Oncology Therapeutics, Inc.	Chief Med & Dev Officer	1	Oct 5
CRBPCorbus Pharmaceuticals Holdings, Inc.	Director	1	Sep 15

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
BBOTBridgeBio Oncology Therapeutics, Inc.	Oct 1	Oct 5	F	1,047	$3.94	$4,125	43,529	No	Form 4
CRBPCorbus Pharmaceuticals Holdings, Inc.	Sep 14	Sep 15	S	2,000	$7.84	Sale −$15,683	9,383	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.